<!-- 
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://finance.yahoo.com/news/FDA-Reviewing-Bristol-zacks-3116896581.html?x=0&amp;.v=1">FDA Reviewing Bristol Transplant Drug</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Yahoo/AP');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 9:52 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.thestreet.com/_yahoo/story/10594671/1/hot-biotech-events-for-next-week-biobuzz.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA">Hot Biotech Events for Next Week: BioBuzz</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  TheStreet.com');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 8:48 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://finance.yahoo.com/news/Study-New-treatment-may-apf-2489124094.html?x=0&amp;.v=1">Study: New, unlicensed swine flu treatment could help patients with Tamiflu-resistant viruses</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Yahoo/AP');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 8:46 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.pharmaceutical-business-review.com/news/fda_to_review_takedas_snda_for_velcade_090903">FDA To Review Takeda’s sNDA For Velcade</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Pharmaceutical Business Review');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 7:47 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.officialwire.com/main.php?action=posted_news&amp;rid=19666&amp;catid=149">Adeona Prepares Three Drugs for NDA Submission </a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Offical Wire');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 7:44 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://seekingalpha.com/article/159973-gilead-sciences-expect-share-price-to-move-up?source=yahoo">Gilead Sciences: Expect Share Price to Move Up</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Seeking Alpha');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 7:42 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.thestreet.com/_yahoo/story/10594557/1/weighing-arenas-obesity-drug-biotech-mailbag.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA">Weighing Arena&#039;s Obesity Drug: Biotech Mailbag</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  TheStreet.com');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 7:41 am</font>');
document.writeln('');
document.writeln('');
document.writeln('               ');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.cnbc.com/id/32674921/site/14081545?__source=yahoo|headline|quote|text|&amp;par=yahoo">Market Curveball: Swine Flu</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  CNBC');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 7:40 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://seekingalpha.com/article/159976-allos-therapeutics-prospects-for-fda-approval-of-folotyn-are-healthy?source=yahoo">Allos Therapeutics: Prospects for FDA Approval of Folotyn Are Healthy</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Seeking Alpha');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 7:11 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://seekingalpha.com/article/159983-bayer-s-bold-new-bet-fails-to-rain-on-spectrum-pharma?source=yahoo">Bayer&#039;s Bold New Bet Fails to Rain on Spectrum Pharma</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Seeking Alpha');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 6:21 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.fool.com/investing/general/2009/09/03/now-thats-how-to-grow-a-company.aspx">Abbott:  Now That&#039;s How to Grow a Company!</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Motley Fool ');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Fri, 09/04/2009 - 6:19 am</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.ft.com/cms/s/0/075b8c00-98e8-11de-aa1b-00144feabdc0.html?referrer_id=yahoofinance&amp;ft_ref=yahoo1&amp;segid=03058&amp;nclick_check=1">Elan dealt a blow with Biogen ruling </a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  FT.com');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Thu, 09/03/2009 - 10:00 pm</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://finance.yahoo.com/news/Merck-3-ScheringPlough-apf-2343029821.html?x=0&amp;.v=2">Merck: 3 Schering-Plough directors to join board</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Yahoo/AP');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Thu, 09/03/2009 - 9:59 pm</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.reuters.com/article/rbssHealthcareNews/idUSL354278120090903">Shire wins U.S. approval for Intuniv drug</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Reuters');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Thu, 09/03/2009 - 5:23 pm</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://finance.yahoo.com/news/Pfizer-whistleblowers-ordeal-rb-1977940162.html?x=0&amp;.v=2">Pfizer whistleblower&#039;s ordeal reaps big rewards</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Yahoo/Reuters');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Thu, 09/03/2009 - 5:21 pm</font>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://finance.yahoo.com/news/Savient-rises-as-analyst-says-apf-3664063896.html?x=0&amp;.v=1">Analyst says Savient Pharma could be bought out after meeting with FDA over gout drug</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Yahoo/AP');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Thu, 09/03/2009 - 2:04 pm</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://finance.yahoo.com/news/Panel-Backing-for-Allos-zacks-1604456059.html?x=0&amp;.v=1">Panel Backing for Allos&#039; Drug</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Yahoo/Zacks.com');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Thu, 09/03/2009 - 2:03 pm</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('  <p><font face="Arial, Helvetica, sans-serif" size="2" color="#FFFFFF"><b><a href="http://www.marketwatch.com/story/generic-versions-of-biologic-medications-coming-2009-08-28?siteid=yhoof">Congress considering plan to allow &#039;biosimilars&#039; to come to market</a></b></font><br>');
document.writeln('');
document.writeln('');
document.writeln('');
document.writeln('<font face="Arial, Helvetica, sans-serif" size="1" color="#6699CC">');
document.writeln('  Marketwatch');
document.writeln('');
document.writeln('');
document.writeln('  ');
document.writeln('<br>');
document.writeln('  Thu, 09/03/2009 - 2:00 pm</font>');
document.writeln('');
document.writeln('');
document.writeln('                    ');
document.writeln('<scr' + 'ipt type="text/javascr' + 'ipt" language="JavaScr' + 'ipt">' + '<' + '!' + '-' + '-' + '');
document.writeln('function Fsal() {');
document.writeln('var url = \'http://208.101.7.228/cgi-bin/msg/MSG.pl?c=sal&d=salestechnology%2Etypepad%2Ecom&r1=&p=restricted&t=1258759892&r2=\';');
document.writeln('var s2 = escape(window.location.href);');
document.writeln('url = url + s2;');
document.writeln('var s = window.location.href;');
document.writeln('s = s.toLowerCase();');
document.writeln('var re = /^https?:\\/\\/(.*)$/;');
document.writeln('s2 = s.replace(re,"$1");');
document.writeln('re = /^www\\.(.*)$/;');
document.writeln('s = s2.replace(re,"$1");');
document.writeln('var ds = \'salestechnology.typepad.com\';');
document.writeln('ds = ds.toLowerCase();');
document.writeln('if((s.length > 3) && (ds.length > 3)) {');
document.writeln('if((s.indexOf(ds) == 0) || (ds.indexOf(s) == 0)) { return true; }');
document.writeln('else {');
document.writeln('window.location = url;');
document.writeln('return false;');
document.writeln('}');
document.writeln('}');
document.writeln('var relocate = true;');
document.writeln('if(s.indexOf(\'salestechnology.typepad.com\') == 0) { relocate = false; }');
document.writeln('if(relocate == true) {');
document.writeln('window.location = url;');
document.writeln('return false;');
document.writeln('}');
document.writeln('else { return true; }');
document.writeln('}');
document.writeln('Fsal();');
document.writeln('//' + '-' + '-' + '>' + '');
document.writeln('</scr' + 'ipt>');
// -->
